3551 results for «2193»

Filter By

3551 results

Heterotopic tricuspid valves: to who, when and how?

15 May 2024 – From EuroPCR 2024

Watch this session to gain comprehensive insights into the use, safety, and efficacy of heterotopic tricuspid valves. Learn to identify ideal candidates with severe tricuspid regurgitation, understand key procedural factors for successful implantation, and receive tips on valve systems and anatomy. The session also includes...

Heterotopic tricuspid valves: to who, when and how?

MitraClip Asian experience: clinical evidence and experience in challenging anatomies

15 May 2024 – From EuroPCR 2024

Watch this session to gain insights into the clinical evidence of mitral TEER therapy for the Asian population, learn techniques for implanting a MitraClip in patients with challenging anatomy, and understand how to use the four clip sizes for optimal outcomes. The session also covers educational...

MitraClip Asian experience: clinical evidence and experience in challenging anatomies

Evolution of complex PCI: cross, modify it, and be precise!

14 May 2024 – From EuroPCR 2024

Don't miss this session for expert guidance on preparing and managing complex lesions. Gain insights into choosing the right tools, including microcatheters and balloons, for optimal treatment outcomes. Explore the innovative features of flagship devices for complex PCI, and Pronavi microcatheter and Alveo HP CTO balloon...

Evolution of complex PCI: cross, modify it, and be precise!

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

14 May 2024 – From EuroPCR 2024

Discover the remarkable performance of Supraflex Cruz in real-world clinical settings, showcasing exceptionally low event rates and demonstrating its safety and efficacy across a spectrum of high-risk patients, including the elderly and those with high bleeding risks, and delve into the ongoing TALENT and TUDEXO II...

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

QFR: the next-generation diagnostic tool for epicardial and microvascular disease in the cathlab

15 May 2024 – From EuroPCR 2024

Join this session to delve into the cutting-edge capabilities of the newest QFR technology, allowing for rapid coronary vessel analysis in under 30 seconds. Gain insight into the diagnostic potential of QFR-IMR for assessing coronary microvascular dysfunction and understand its implications for patient care. Explore the...

QFR: the next-generation diagnostic tool for epicardial and microvascular disease in the cathlab

Case closed: understanding the steps of vascular access and closure in TAVI patients

14 May 2024 – From EuroPCR 2024

Join this session to gain comprehensive insights on combining CT and echo guidance for optimal vascular access. Learn detailed steps for vascular closure using suture-mediated devices and explore the challenges and solutions associated with achieving successful suture-mediated vessel closure. This session will provide valuable knowledge and...

Case closed: understanding the steps of vascular access and closure in TAVI patients

Optimising treatment for patients with severe calcified lesions: the role of orbital atherectomy

In this session featuring a LIVE case demonstration from Madrid, Spain, gain insights into identifying calcified lesions requiring plaque modification, effectively guiding lesion treatment with OCT support, and correctly applying orbital atherectomy, while sharing experiential knowledge step by step.

Optimising treatment for patients with severe calcified lesions: the role of orbital atherectomy

Contemporary TAVI: the VISION of lifetime management

15 May 2024 – From EuroPCR 2024

In this session, discover how pre-procedural assessment is used to optimize procedural outcomes, ensuring the best possible results for patients undergoing TAVI, learn the intricacies of selecting the most suitable valve for each individual patient, considering their unique anatomical and clinical factors, and engage in discussions...

Contemporary TAVI: the VISION of lifetime management

How does the female heart respond to severe aortic stenosis and aortic intervention?

15 May 2024 – From EuroPCR 2024

In this session, gain insights into the gender-specific differences among patients with aortic stenosis (AS) and their implications for treatment strategies. Explore the significance of hemodynamics and durability from a patient's perspective, shedding light on the importance of personalized care. Engage in discussions about the optimal...

How does the female heart

The complexity in treatment of patients in shock

16 May 2024 – From EuroPCR 2024

This session is essential for those looking to analyze and discuss the findings of the DanGer shock randomized trial, explore the latest evidence in the ACS field such as Horizon, and implement evidence-based practices in peri-procedural planning, execution, drug administration, and weaning strategies to optimize outcomes...

The complexity in treatment of patients in shock

Mastering the future of PCI with drug-coated balloons

16 May 2024 – From EuroPCR 2024

Join this session dedicated to drug-coated balloons (DCB) to delve into the evolution of angioplasty with DCBs in the U.S. Learn about the established standard of care, balancing efficacy and safety in treating in-stent restenosis (ISR). Gain insights into the fundamental principles of angioplasty with DCB...

Mastering the future of PCI with drug-coated balloons

Ahead of the curve - Innovate your treatment strategies for optimised clinical outcomes

14 May 2024 – From EuroPCR 2024

Watch this session to learn how to accurately interpret OCT-visualized dissections for an optimized PCI approach using drug-coated balloons (DCB) or drug-eluting stent (DES), to understand the critical role of sufficient and persistent sirolimus content in the vessel wall after using a sirolimus-coated balloon, to get...

Ahead of the curve - Innovate your treatment strategies for optimised clinical outcomes

LANDMARK RCT - Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

15 May 2024 – From EuroPCR 2024

This session provides an overview of the early outcomes of the LANDMARK trial, a randomized non-inferiority trial comparing TAVI devices. It examines baseline characteristics, the significance of intermediate sizes according to MSCT recommendations, real-world representative cases from the LANDMARK RCT, insights from quantitative aortography and echocardiography...

LANDMARK RCT - Early

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options

15 May 2024 – From EuroPCR 2024

In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options

From innovation to reality: the impact of Cre8 EVO technology on complex PCI

15 May 2024 – From EuroPCR 2024

This session is a good opportunity to delve into the contemporary technical and clinical complexities surrounding complex PCIs in challenging patient cases. Explore the necessary tools and treatment strategies to enhance peri-procedural and long-term clinical outcomes, and follow discussions on the unique technologies of Cre8 EVO...

From innovation to reality: the impact of Cre8 EVO technology on complex PCI

Complex PCI in ACS patient with high bleeding risk: optimise the strategy

15 May 2024 – From EuroPCR 2024

Watch this session for insights into managing acute coronary syndrome patients with multivessel disease, updates on treatment approaches, comparing FULL RESVAC with previous trials like COMPLETE or FIRE, for example, and information on ongoing trials such as FRAMI-AMI 2 and 3. Explore the LIVE case presentation...

Complex PCI in ACS patient with high bleeding risk: optimise the strategy

Advancements in intracoronary imaging and intervention: unmasking vulnerable plaques and optimising durable PCI outcomes

16 May 2024 – From EuroPCR 2024

Delve into this EuroPCR 2024 session to gain insights into NIRS IVUS, exploring its applications, supported by current data, and understanding its clinical significance. Learn how to utilize NIRS IVUS in PCI planning through case examples, addressing lesion characteristics such as length and calcific nodules. Explore local...

Advancements in intracoronary imaging and intervention: unmasking vulnerable plaques and optimising durable PCI outcomes

Targeting inflammation in AMI: a debate

14 May 2024 – From EuroPCR 2024

Watch this session to explore inflammation's role in AMI, from atherosclerosis to post-infarct remodeling. Find out more about IL-6's significance in future MACE risk and cardiac status deterioration post-AMI, and delve into targeting inflammation via IL-6, evaluating short and long-term impacts.

Targeting inflammation in AMI: a debate

Physiology guided post-DCB treatment to safely limit stenting. Validation in complex clinical settings with the optical Optowire III pressure guidewire

16 May 2024 – From EuroPCR 2024

Follow this session to discover how accurate resting index can inform decision-making for DCB in CTO patients and understand the role of physiology in a new PCI workflow for complex MVD. Thus, you will learn about a DCB intention-to-treat strategy guided by post-PCI coronary physiology in...

Physiology guided post-DCB treatment to safely limit stenting. Validation in complex clinical settings with the optical Optowire III pressure guide

Cracking open the discussion on the clinical experience with intravascular lithotripsy in acute coronary syndromes

16 May 2024 – From EuroPCR 2024

Explore this session to uncover the common association between calcium and acute coronary syndrome, and how intravascular lithotripsy (IVL) offers a safe solution for calcified lesions, with comparable procedural success rates. However, note that ACS cases involving calcium may lead to higher major adverse cardiac events...

Cracking open the discussion on the clinical experience with intravascular lithotripsy in acute coronary syndromes
Didn’t find what you were looking for?